ABEM Pain Medicine flashcards
ABEM Pain Medicine · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- A-delta fibers
- Thinly myelinated primary afferent fibers with fast conduction velocity that transmit sharp, well-localized first pain via glutamate release onto dorsal horn neurons.
- C fibers
- Unmyelinated, slow-conducting nociceptors that mediate dull, burning second pain and release substance P and glutamate in the dorsal horn.
- Substantia gelatinosa
- Lamina II of the dorsal horn, rich in interneurons and opioid receptors, where primary afferent input is modulated before projection to higher centers.
- Gate control theory
- Melzack and Wall model in which large-diameter Abeta mechanoreceptor input activates inhibitory interneurons in the dorsal horn, reducing transmission of nociceptive signals from A-delta and C fibers.
- Mu opioid receptor
- Gi-coupled receptor whose activation inhibits adenylyl cyclase, opens potassium channels, and closes calcium channels, reducing neuronal excitability and neurotransmitter release.
- Local anesthetic mechanism
- Bind the intracellular side of voltage-gated sodium channels, blocking sodium influx and action potential propagation; inflamed tissue has lower pH, increasing ionized drug and slowing onset.
- DN4 questionnaire
- Ten-item clinician-administered screening tool for neuropathic pain; a total score of 4 or more out of 10 suggests neuropathic pain and warrants further evaluation.
- SOCRATES mnemonic
- A mnemonic for pain history: Site, Onset, Character, Radiation, Associated symptoms, Time course, Exacerbating and relieving factors, and Severity.
- Allodynia
- Pain produced by a stimulus that does not normally provoke pain, such as light touch, and often indicates central or peripheral sensitization in neuropathic states.
- Hyperalgesia
- An increased painful response to a stimulus that is normally painful, reflecting sensitization of nociceptors or central pain pathways.
- Red flags back pain
- Features suggesting serious spinal pathology, including fever, unexplained weight loss, cancer history, bowel or bladder dysfunction, saddle anesthesia, and progressive neurologic deficit.
- Acetaminophen maximum dose
- Usual adult maximum is 4,000 mg per day; consider limiting to 3,000 mg or less in hepatic impairment, chronic alcohol use, malnutrition, or low body weight.
- Tramadol risks
- Weak mu-opioid agonist and serotonin-norepinephrine reuptake inhibitor; lowers seizure threshold, can precipitate serotonin syndrome, and is contraindicated with monoamine oxidase inhibitors.
- Buprenorphine ceiling effect
- Partial mu agonist with high receptor affinity; respiratory depression plateaus at higher doses, but it can precipitate withdrawal in patients receiving full agonist opioids.
- Gabapentin mechanism
- Binds the alpha-2-delta subunit of voltage-gated calcium channels on presynaptic terminals, reducing calcium influx and release of excitatory neurotransmitters such as glutamate and substance P.
- Duloxetine indication
- Serotonin-norepinephrine reuptake inhibitor approved for diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain; efficacy is independent of coexisting depression.
- Meperidine metabolite
- Normeperidine, a renally cleared active metabolite that accumulates with repeated dosing and can cause myoclonus, agitation, and seizures; meperidine is avoided for chronic pain.
- Medial branch block
- Diagnostic injection of local anesthetic onto the medial branch of the dorsal ramus to identify facet joint-mediated pain; concordant relief of 80% or more supports radiofrequency denervation.
- Transforaminal epidural risk
- Particulate corticosteroids can occlude small radicular arteries and cause spinal cord infarction; nonparticulate dexamethasone is often preferred, and injection should stop if vascular uptake occurs.
- Stellate ganglion block
- Injection near the C6 anterior tubercle targeting the sympathetic chain; successful block produces Horner syndrome with ptosis, miosis, and anhidrosis, and may relieve complex regional pain syndrome.
- Spinal cord stimulation
- Implanted epidural electrodes delivering electrical pulses to dorsal columns; paresthesia-based and paresthesia-free waveforms are used mainly for persistent radicular pain after spine surgery.
- Ziconotide
- Intrathecal synthetic conopeptide that blocks N-type voltage-gated calcium channels; it requires slow titration because of risks of confusion, ataxia, and psychiatric symptoms.
- Cognitive behavioral therapy
- Structured psychological treatment targeting maladaptive thoughts and behaviors that maintain pain-related disability; it has strong evidence for improving function and distress in chronic pain.
- Graded exposure
- Behavioral technique in which patients gradually confront feared movements or activities in a planned hierarchy, reducing fear avoidance and restoring function without triggering excessive pain.
- Fear avoidance model
- Model proposing that catastrophic misinterpretation of pain leads to avoidance of activity, deconditioning, and disability, creating a self-reinforcing cycle of chronic pain.
- Pacing
- Activity regulation strategy alternating activity and rest before pain flares, aiming to avoid the overactivity-underactivity cycle and improve sustained function.
- Multidisciplinary pain program
- Coordinated care combining medical management, physical therapy, and psychological intervention, often with group sessions; it improves function and reduces healthcare use in chronic pain.
- Prescription drug monitoring program
- State database of controlled substance prescriptions; querying it before prescribing helps identify multiple prescribers, high doses, and possible misuse.
- Schedule II prescribing
- Controlled substances with high abuse potential and accepted medical use; federal rules prohibit refills, require a written or qualifying electronic prescription, and limit quantity.
- Informed consent elements
- Must include diagnosis, nature and purpose of the proposed procedure, material risks and benefits, alternatives including no treatment, and confirmation of patient understanding and voluntary agreement.
- HIPAA
- Federal law protecting identifiable health information; permitted disclosures include treatment, payment, and operations, while other uses generally require patient authorization or de-identification.
- ALARA principle
- As Low As Reasonably Achievable principle for radiation safety: minimize fluoroscopy time, use pulsed mode and collimation, and maximize distance from the radiation source.